Cipla partners with MSD to manufacture and distribute Molnupiravir drug to treat Covid-19
Cipla has entered into a non-exclusive licensing agreement with MSD (called Merck in the US and Canada) for the manufacturing and distribution of Molnupiravir (EIDD-2801/MK-4482), ... Read More
CORAT begins COR-101 clinical trial in hospitalized Covid patients
CORAT Therapeutics said that it has begun a phase 1b/2 clinical trial of its antibody drug candidate COR-101 for the treatment of hospitalized Covid-19 patients. ... Read More
Russia’s RDIF gets Indian approval for Sputnik V Covid-19 vaccine
The Russian Direct Investment Fund (RDIF) has announced that the Sputnik V Covid-19 vaccine has been approved for use in India by the Drug Controller ... Read More
Dr. Reddy’s secures EUA for Sputnik V vaccine in India for Covid-19 prevention
Dr. Reddy’s Laboratories has secured permission from the Drug Controller General of India (DCGI) for importing the Sputnik V vaccine into India under emergency use ... Read More
Grifols phase 3 Covid-19 trial of hyperimmune globulins fails to meet objective
Spanish pharma company Grifols said that the phase 3 ITAC clinical trial assessing hyperimmune globulins as a treatment for patients hospitalized with Covid-19 has failed ... Read More
Tiziana Life Sciences to launch phase 2 trial of Foralumab in Covid-19
Tiziana Life Sciences said that it plans to launch a phase 2 clinical trial to evaluate the nasal administration of Foralumab in moderate to severe ... Read More
Pfizer begins phase 1 study of Covid drug candidate PF-07321332
Pfizer said that it has initiated a phase 1 study in the US for assessing the oral antiviral therapeutic PF-07321332 against SARS-CoV-2, the virus that ... Read More
Covid antibody candidate AZD7442 : AstraZeneca, US strike deal for additional doses
AstraZeneca has agreed to supply the US government with up to half a million additional doses of AZD7442, the company’s Covid-19 antibody candidate, for a ... Read More
Cytocom gets FDA nod for phase 2 trial of Covid drug candidate CYTO-205
Cytocom has secured clearance from the US Food and Drug Administration (FDA) to undertake a phase 2 clinical trial of CYTO-205 for the treatment of ... Read More
Dr. Reddy’s seeks EUA for Russian Covid-19 vaccine Sputnik V from DCGI
Dr. Reddy’s Laboratories said that it has started the process to seek the emergency use authorization (EUA) for the Russian Covid-19 vaccine Sputnik V from ... Read More